Novo Nordisk

Novo Nordisk to buy Prothena’s heart drug in deal worth up to $1.2 bln

July 12 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO) will acquire U.S. drug developer Prothena Corp's (PRTA.O) experimental heart therapy, PRX004, in a deal…

4 years ago

The battle for the future of the US economy is being led by technology stocks!

The Nasdaq 100 Index outperformed, and the Stoxx 600 Index gained more than 1%, with technology stocks leading the way…

5 years ago